Related Experiment Video

Updated: May 31, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Stroke prevention in atrial fibrillation: current status and near-future directions

Raffaele De Caterina1, Elaine M Hylek

  • 1Institute of Cardiology and Center of Excellence on Aging, G. d'Annunzio University, Chieti, Italy. rdecater@unich.it

The American Journal of Medicine
|July 13, 2011
PubMed

Insights

Preventing stroke in atrial fibrillation (AF) is crucial. Current treatments like vitamin K antagonists are underused, highlighting the need for safer, more effective novel oral anticoagulants for AF patients.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Stroke prevention is key in managing atrial fibrillation (AF).
  • Stroke risk in AF patients is variable, influenced by comorbidities and risk factors.
  • Existing risk stratification tools guide antithrombotic therapy recommendations.

Purpose of the Study:

  • To review the challenges in current stroke prevention strategies for AF.
  • To discuss the limitations of vitamin K antagonists (VKAs) in AF management.
  • To highlight the potential of novel oral anticoagulants (NOACs) in improving thromboprophylaxis.

Main Methods:

  • Literature review of AF management guidelines and anticoagulation therapies.
  • Analysis of risk factors and stroke risk stratification in AF patients.
  • Discussion of the drawbacks of vitamin K antagonists and the advantages of novel oral anticoagulants.

Main Results:

  • Many AF patients do not receive adequate stroke prevention (thromboprophylaxis).
  • Vitamin K antagonists have limitations, including a narrow therapeutic window and drug/food interactions.
  • Novel oral anticoagulants show promise in overcoming VKA limitations, potentially improving safety and adherence.

Conclusions:

  • Underuse of adequate thromboprophylaxis remains a significant issue in atrial fibrillation.
  • Limitations of vitamin K antagonists contribute to suboptimal stroke prevention in AF.
  • Novel oral anticoagulants represent a promising advancement for improving stroke risk management in AF patients.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation09:17

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation

Published on: July 29, 2011

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...